CLEARSIDE BIOMEDICAL INC's ticker is CLSD and the CUSIP is 185063104. A total of 47 filers reported holding CLEARSIDE BIOMEDICAL INC in Q3 2023. The put-call ratio across all filers is 1.66 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,739 | +10.9% | 2,000 | +42.9% | 0.00% | – |
| Q2 2023 | $1,568 | -81.0% | 1,400 | -82.4% | 0.00% | – |
| Q1 2023 | $8,268 | -24.8% | 7,950 | -20.1% | 0.00% | – |
| Q4 2022 | $11,000 | 0.0% | 9,950 | 0.0% | 0.00% | – |
| Q3 2022 | $11,000 | -38.9% | 9,950 | -19.4% | 0.00% | – |
| Q2 2022 | $18,000 | -35.7% | 12,350 | 0.0% | 0.00% | – |
| Q1 2022 | $28,000 | -17.6% | 12,350 | 0.0% | 0.00% | – |
| Q4 2021 | $34,000 | -39.3% | 12,350 | +32.1% | 0.00% | – |
| Q3 2021 | $56,000 | +55.6% | 9,350 | +26.4% | 0.00% | – |
| Q2 2021 | $36,000 | +500.0% | 7,400 | +208.3% | 0.00% | – |
| Q1 2021 | $6,000 | -14.3% | 2,400 | 0.0% | 0.00% | – |
| Q4 2020 | $7,000 | +75.0% | 2,400 | 0.0% | 0.00% | – |
| Q3 2020 | $4,000 | -20.0% | 2,400 | 0.0% | 0.00% | – |
| Q2 2020 | $5,000 | +25.0% | 2,400 | -9.4% | 0.00% | – |
| Q1 2020 | $4,000 | – | 2,650 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACT CAPITAL MANAGEMENT, LLC | 2,462,500 | $11,993,000 | 6.16% |
| ACUTA CAPITAL PARTNERS, LLC | 1,316,268 | $6,410,000 | 2.56% |
| AJU IB Investment Co., Ltd. | 293,555 | $1,430,000 | 0.82% |
| RTW INVESTMENTS, LP | 4,206,765 | $20,487,000 | 0.31% |
| Carmignac Gestion | 3,419,877 | $16,655,000 | 0.19% |
| EAM Investors, LLC | 247,561 | $1,206,000 | 0.19% |
| Curi Wealth Management, LLC | 25,000 | $121,000 | 0.06% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 316,600 | $1,542,000 | 0.03% |
| TWO SIGMA ADVISERS, LP | 990,000 | $4,821,000 | 0.01% |
| CAXTON ASSOCIATES LP | 24,677 | $120,000 | 0.01% |